T cells isolated from HT-29 tumours 24 h after the last dose of injection with VV-αCEA TCE and PBMCs showed an increase in expression of the T cell activation marker CD69, while injection of VV-αCEA CTRL had little effect relative to PBS treatment (Figure 3D). Here, CD69 is linked to neoplasm.